The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Cullinan Therapeutics Inc (NASDAQ: CGEM) closed at $7.62 in the last session, down -3.67% from day before closing price of $7.91. In other words, the price has decreased by -$3.67 from its previous closing price. On the day, 1.25 million shares were traded.
Ratios:
We take a closer look at CGEM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 11.62 and its Current Ratio is at 11.62. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $30.
On May 01, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $40.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 25 ’25 when Jones Jeffrey Alan sold 4,895 shares for $8.53 per share. The transaction valued at 41,754 led to the insider holds 174,164 shares of the business.
AHMED NADIM sold 12,529 shares of CGEM for $106,872 on Feb 25 ’25. The President and CEO now owns 430,621 shares after completing the transaction at $8.53 per share. On Feb 25 ’25, another insider, Michaelson Jennifer, who serves as the Chief Scientific Officer of the company, sold 3,756 shares for $8.53 each. As a result, the insider received 32,039 and left with 142,004 shares of the company.
Stock Price History:
Over the past 52 weeks, CGEM has reached a high of $28.11, while it has fallen to a 52-week low of $6.85. The 50-Day Moving Average of the stock is -6.16%, while the 200-Day Moving Average is calculated to be -40.20%.
Shares Statistics:
A total of 58.70M shares are outstanding, with a floating share count of 35.77M. Insiders hold about 39.38% of the company’s shares, while institutions hold 74.43% stake in the company.
